Interestingly, hepcidin levels increase in some non-bacterial infections such as in SARS-CoV-2 (COVID-19) patients, suggesting potentially conserved inflammatory responses that modulate Hepcidin (18). The gene discussed is HAMP; the disease is bacterial infectious disease.